ELEV (elevationoncology.com) Earnings per share growth rate in current year

Official company branding of elevationoncology.com (ELEV)

Elevation Oncology relies on investments and grants to develop precision medicines. Year-over-year EPS dynamics clearly demonstrate the market valuation of these processes, where the 15.70 level represents the current figure. The brand's reputation is built on precise DNA analysis of rare forms of cancer, while liquidity remains balanced to ensure the systematic funding of ongoing clinical trials.

Earnings per share growth in current year: elevationoncology.com (ELEV) for 07/04/2022 - 08/02/2025

Comprehensive metric breakdowns and analytics for Elevation Oncology, Inc. (ELEV)

- business market valuation indicators:
Fundamental valuation:Elevation Oncology
Signature product of elevationoncology.com

For a fundamental valuation of Elevation Oncology (ELEV), it is essential to understand the dynamics of its market capitalization within the context of seribatumab development. This indicator captures the annual difference in earnings per share, measuring the growth or decline rates of business profitability. By analyzing the distribution of the annual change in earnings per share, an investor can assess the financial stability of Elevation Oncology (ELEV) as it strives to monopolize the NRG1-mutated tumor therapy niche.

Key competitors

Earnings per share growth rate in current year BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Earnings growth in current year|Earnings per share growth rate in current year revmed.com RVMD|Earnings growth in current year AAPG|Net earnings per share growth this year CG Oncology CGON|Earnings per share growth in current year UroGen URGN|Expected net earnings per share growth this year Bicara Bio (BCAX)|PSNL - Earnings per share growth in current year|ERAS - Earnings growth in current year|DCTH: Earnings growth in current year|Y-mAbs Therapeutics, Inc. (YMAB) - Earnings growth in current year|Net earnings per share growth this year AURA|Earnings per share growth rate in current year candeltx.com CADL|Earnings growth in current year ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Earnings per share increase in current year|Earnings growth in current year ACTU (Actuate Therapeutics Inc)|Earnings per share increase in current year CTOR|tuhurabio.com - Earnings growth in current year|Earnings per share increase in current year TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Earnings per share growth in current year|WHWK - Expected net earnings per share growth this year|Earnings per share growth in current year tscan.com|CSBR: Earnings per share increase in current year|Earnings per share growth in current year XBiotech USA (XBIT)|CVM: Earnings per share trend in current year|Earnings per share growth in current year ostherapies.com OSTX|Net earnings per one share growth for the current year RADX (Radiopharm Theranostics Limited)|Artiva - Earnings growth in current year|ANL: Earnings per share growth in current year|VERU: Earnings growth in current year|Earnings per share trend in current year TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Earnings growth in current year|Earnings per share growth rate in current year renovarobio.com RENB|Earnings per share growth in current year muraloncology.com (MURA)|Net earnings per one share growth for the current year KAPA|Earnings growth in current year OKUR (onkuretherapeutics.com)|Net earnings per one share growth for the current year GDTC (CytoMed)|Curis - Earnings growth in current year|APLM: Earnings per share growth in current year|Tharimmune (THAR) - Earnings per share growth in current year|Net earnings per share growth this year Advanced Biomed Inc.|GNPX (Genprex Inc) - Earnings growth in current year|Calidi Biotherapeutics (CLDI) - Expected net earnings per share growth this year|Earnings growth in current year SBFM|Earnings per share growth in current year XBIO (Xenetic Biosciences, Inc.)|Earnings growth in current year SLRX (salariuspharma.com)|PPBT - Net earnings per share growth this year|AONC - Earnings per share growth in current year|Earnings per share increase in current year BGNE (BeOne Medicines)|CKPT: Earnings growth in current year|Earnings per share growth rate in current year iCAD Inc. (ICAD)|IKNA (Ikena) - Earnings growth in current year|Net earnings per share growth this year Notable Labs (NTBL)|Earnings growth in current year VIRX|Net earnings per share growth this year MorphoSys Corporation MOR|NAYA Biosciences - Net earnings per share growth this year|Net earnings per share change in current year Ascentage Pharma